Skip to Content Skip to Content
  • Business & Law
  • Is there an AI bubble and what happens if it bursts?

    Wharton’s Itay Goldstein discusses financial bubbles, the mechanics of betting against them, and the risks facing the AI boom.

    3 min. read

    Traders at the New York Stock Exchange looking at monitors.
    Wall Street rides an AI-fueled rally that has pushed major indices to new highs that’s driven largely by a handful of dominant tech firms. As enthusiasm around artificial intelligence reshapes markets and concentrates risk, questions are mounting about whether the surge reflects durable growth or the familiar shape of a speculative bubble. Wharton finance crises expert Itay Goldstein explains how bubbles form, why they can be so dangerous, and what today’s AI boom shares—and does not—with past market madness like the one described in “The Big Short.”
     
    (Image: Getty / Spencer Platt)

    Recent Articles

  • More Articles
  • The Fed explained: What it does and why it matters
    Photo of the Federal Reserve facade

    (Image: Lance Nelson)

    The Fed explained: What it does and why it matters

    Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy

    May 13, 2026

    Fighting oral cancer with bioengineered chewing gum
    A latex-gloved hand hoding a petri dish of medical chewing gum.

    A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

    (Image: Kevin Monko/Penn Dental Medicine)

    Fighting oral cancer with bioengineered chewing gum

    Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

    Apr 20, 2026